IgA Deficiency: Clinical Trials

1 completed, 1 unknown. 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 1	1	Completed 1

Follow IgA Deficiency: new trials by email Literature Review of IgA Deficiency trials Research Report on IgA Deficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Epidemiology of IgA Selective Deficiency - Clinical Manifestations and Risk of Transmission COVID-19		Unknown	University Hospital, Strasbourg, France	120	2022-04-09	2023-12-19
B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency B-Lymphocyte Stimulator (BLyS) - IgA Deficiency	Phase 1	Completed	National Cancer Institute (NCI)	20	2001-10-01	2016-09-22

Narrower conditions

Neoplasms (2)  ·  COVID-19 (1)  ·  Immunologic Deficiency Syndromes (1)

Broader conditions

Blood Protein Disorders (2)  ·  Dysgammaglobulinemia (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)

Interventions

B-Cell Activating Factor (1)

Sponsors

National Cancer Institute (NCI) (1)  ·  University Hospital, Strasbourg, France (1)

Countries

France (1)  ·  United States (1)